A Phase 1 Study of ABC008 in Adult Patients With Inclusion Body Myositis (IBM)

  • participants needed
  • sponsor
    Abcuro, Inc.
Updated on 23 January 2022
inclusion body myositis


An open-label, ascending dose study for adult patients with inclusion body myositis (IBM).

Condition Myositis, INCLUSION BODY MYOSITIS, Idiopathic Inflammatory Myopathies
Treatment ABC008
Clinical Study IdentifierNCT04659031
SponsorAbcuro, Inc.
Last Modified on23 January 2022

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note